Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004116862 | SCV003601294 | uncertain significance | not specified | 2024-11-09 | criteria provided, single submitter | clinical testing | The c.194G>A (p.R65Q) alteration is located in exon 2 (coding exon 1) of the B3GALT2 gene. This alteration results from a G to A substitution at nucleotide position 194, causing the arginine (R) at amino acid position 65 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |